Patent application number | Description | Published |
20080280919 | QUINOLINE AND QUINAZOLINE DERIVATIVES HAVING AFFINITY FOR 5HT1-TYPE RECEPTORS - Disclosed are methods for use of compounds of formula (I) in combination with other active substances in the treatment of CNS disorders such as depression or anxiety. | 11-13-2008 |
20080280969 | Novel Compounds - The invention provides a compound of formula (I), pharmaceutical compositions thereof, and methods of treatment using the same. | 11-13-2008 |
20080293753 | Novel Compounds - The invention relates to quaternary α-aminocarboxyamide derivatives of formula (I), wherein R | 11-27-2008 |
20080306122 | Novel Compounds - Compounds of formula (I) wherein the variables are defined herein, pharmaceutical compositions thereof and methods for treatment using the same. | 12-11-2008 |
20090312546 | QUINOLINE AND QUINAZOLINE DERIVATIVES HAVING AFFINITY FOR 5HT1-TYPE RECEPTORS - Disclosed are methods for the preparation of compounds of formula (I): | 12-17-2009 |
20100105754 | 5-(4PHENYL)PROLINAMIDE FOR TREATMENT OF EPILEPSY - The invention provides a compound of formula (I), a solvate, a salt or prodrug thereof, | 04-29-2010 |
20100130583 | PROLINAMIDE DERIVATIVES AS MODULATORS OF VOLTAGE-GATED SODIUM CHANNELS - The invention relates to quaternary α-aminocarboxyamide derivatives of formula (I) and their pharmaceutically salts or solvates | 05-27-2010 |
20100204273 | Quinoline and Quinazoline Derivatives Having Affinity for 5HT1-Type Receptors - Disclosed are methods for use of compounds of formula (I) in the treatment of CNS disorders such as dysthymia, schizophrenia, panic disorder, obsessive compulsive disorder, post-traumatic stress disorder, pain, and memory disorders: | 08-12-2010 |
20100324022 | NOVEL COMPOUNDS - Compounds of formula (I), pharmaceutical compositions thereof, and methods for treatment using the same. | 12-23-2010 |
20110098335 | NOVEL COMPOUNDS - The invention provides a compound of formula (I), a solvate, a salt or prodrug thereof, | 04-28-2011 |
20120022056 | FUSED TRICYCLIC DERIVATIVES FOR THE TREATMENT OF PSYCHOTIC DISORDERS - Compounds of formula (I) wherein R | 01-26-2012 |